AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.823
-0.027 (-3.21%)
Nov 7, 2024, 3:24 PM EST - Market open
AEON Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -305.52 | -384.63 | -52.56 | -55.64 | -32.91 | 172.92 | Upgrade
|
| Depreciation & Amortization | 0.1 | 0.1 | 0.07 | 0 | - | 1.26 | Upgrade
|
| Other Amortization | - | - | 0.33 | 1.98 | 0.83 | 0.61 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -254.11 | Upgrade
|
| Asset Writedown & Restructuring Costs | 348 | 348 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.35 | 42.33 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 0.14 | -0.14 | Upgrade
|
| Stock-Based Compensation | 7.81 | 7 | 5.89 | 5.22 | 4.79 | 5.25 | Upgrade
|
| Other Operating Activities | -85.83 | -15.55 | 4.41 | 18.59 | 16.59 | -12.9 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | - | -0.02 | Upgrade
|
| Change in Inventory | - | - | - | - | - | -7.39 | Upgrade
|
| Change in Accounts Payable | -3.49 | -4.59 | 6.61 | -0.9 | 0.67 | 3.92 | Upgrade
|
| Change in Other Net Operating Assets | -4.48 | 1.85 | -0.35 | 2.31 | 0.79 | 3.54 | Upgrade
|
| Operating Cash Flow | -43.4 | -47.83 | -35.58 | -28.43 | -9.46 | -44.73 | Upgrade
|
| Capital Expenditures | - | - | -0.31 | -0.17 | - | - | Upgrade
|
| Divestitures | - | - | - | - | -1.27 | -36.5 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -1.69 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -79.1 | Upgrade
|
| Investing Cash Flow | - | - | -0.31 | -0.17 | -1.27 | -117.29 | Upgrade
|
| Long-Term Debt Issued | - | 14 | 44.5 | 15 | 25.41 | 83.91 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.3 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -3.99 | - | - | -74.23 | Upgrade
|
| Total Debt Repaid | - | - | -3.99 | - | -0.3 | -74.23 | Upgrade
|
| Net Debt Issued (Repaid) | 15 | 14 | 40.51 | 15 | 25.11 | 9.68 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0.06 | Upgrade
|
| Other Financing Activities | - | - | - | -1.44 | -0.54 | 63.6 | Upgrade
|
| Financing Cash Flow | 15 | 14 | 40.51 | 13.56 | 24.57 | 73.21 | Upgrade
|
| Net Cash Flow | -28.4 | -33.83 | 4.62 | -15.04 | 13.84 | -88.8 | Upgrade
|
| Free Cash Flow | -43.4 | -47.83 | -35.89 | -28.6 | -9.46 | -44.73 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -375.73% | -1332.29% | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -0.51 | -0.26 | -0.23 | -1.43 | -6.73 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 3.46 | Upgrade
|
| Levered Free Cash Flow | -24.6 | -25.48 | -16.79 | -14.85 | -2.94 | -33.72 | Upgrade
|
| Unlevered Free Cash Flow | -24.6 | -25.48 | -16.79 | -14.85 | -2.93 | -29.66 | Upgrade
|
| Change in Net Working Capital | 5.13 | -0.35 | -6.18 | -1.19 | -1.68 | 4.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.